LSPIX
Price
$5.53
Change
+$0.01 (+0.18%)
Updated
Jul 13 closing price
Net Assets
71.03M
ONAIX
Price
$17.39
Change
-$0.16 (-0.91%)
Updated
Jul 13 closing price
Net Assets
967.62M
Interact to see
Advertisement

LSPIX vs ONAIX

LSPIX vs ONAIX Comparison Chart in %
View a ticker or compare two or three
VS
LSPIX vs. ONAIX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSPIX is a Hold and ONAIX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ONAIX has more cash in the bank: 968M vs. LSPIX (71M). LSPIX pays higher dividends than ONAIX: LSPIX (8.81) vs ONAIX (0.93). LSPIX was incepted earlier than ONAIX: LSPIX (13 years) vs ONAIX (21 years). LSPIX (3.24) is less costly to investors than ONAIX (1.10). LSPIX is a more actively managed with annual turnover of: 66.00 vs. ONAIX (33.00). ONAIX has a lower initial minimum investment than LSPIX: ONAIX (1000) vs LSPIX (100000). ONAIX annual gain was more profitable for investors over the last year : 16.22 vs. LSPIX (10.92). LSPIX return over 5 years is better than : 16.61 vs. ONAIX (12.45).
LSPIXONAIXLSPIX / ONAIX
Total Expense Ratio3.191.10290%
Annual Report Gross Expense Ratio3.241.10295%
Fund Existence13 years21 years-
Gain YTD6.89212.14157%
Front LoadN/AN/A-
Min. Initial Investment100000100010,000%
Min. Initial Investment IRAN/AN/A-
Net Assets71M968M7%
Annual Yield % from dividends8.810.93945%
Returns for 1 year10.9216.2267%
Returns for 3 years33.3536.0193%
Returns for 5 years16.6112.45133%
Returns for 10 years57.6228.77200%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SCLS25.06N/A
N/A
Stoneport Advisors Commodity Long Short ETF
DAX44.40N/A
N/A
Global X DAX Germany ETF
NRES31.32N/A
N/A
Xtrackers RREEF Global Natrl Res ETF
VTEL103.95-0.07
-0.06%
Vanguard Long-Term Tx-Exm Bd ETF
IHE99.99-0.52
-0.52%
iShares US Pharmaceuticals ETF